Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)

Matthew J. Wieduwilt*, Wendy Stock, Anjali Advani, Selina Luger, Richard A. Larson, Martin Tallman, Frederick Appelbaum, Mei Jie Zhang, Khalid Bo-Subait, Hai Lin Wang, Vijaya Raj Bhatt, Bhagirathbhai Dholaria, Mary Eapen, Mehdi Hamadani, Omer Jamy, Tim Prestidge, Michael Pulsipher, David Ritchie, David Rizzieri, Akshay SharmaPere Barba, Brenda M. Sandmaier, Marcos de Lima, Partow Kebriaei, Mark Litzow, Wael Saber, Daniel Weisdorf

*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS